Tissium - Biomorphic programmable polymers

Creating the future of tissue reconstruction

Learn more

A new era of reconstructive polymers

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures:

To reconstruct damaged tissue and restore its natural function.

Biomorphic programmable polymers

Our proprietary biomorphic programmable polymers enable tissue reconstruction and can be adapted for use in multiple clinical areas

Biomorphic

Conforms to and integrates with surrounding tissue to enable tissue reconstruction

Programmable

Polymer building blocks can be adjusted to match tissue-specific requirements

Therapeutic areas

 

We design solutions for different tissue types for both open surgery and minimally invasive procedures

Peripheral Nerve

Cardiovascular

Ear, Nose, Throat

Gastrointestinal

Achievements

3

CE Marks

18

Patents Granted

26

Patents Pending

8

Publications

Partners

  • Masachusetts Institute of Technolofy
  • UCD-DUBLIN
  • brigham and women´s hospital
  • Hôpital Européen Georges Pompidou
  • Heart Center Munich
  • Assistance Hopitaux Publique de Paris